Comparison of EQ-5D and SF-6D utilities in Pompe disease

被引：0
|
作者：
T. A. Kanters
W. K. Redekop
M. E. Kruijshaar
A. T. van der Ploeg
M. P. M. H. Rutten-van Mölken
L. Hakkaart
机构：
[1] Erasmus University Rotterdam,Department of Health Policy and Management, Institute for Medical Technology Assessment
[2] Erasmus MC University Medical Center,Center for Lysosomal and Metabolic Diseases
[3] Erasmus MC University Medical Center Rotterdam,Division of Metabolic Diseases and Genetics, Department of Pediatrics
来源：
Quality of Life Research | 2015年 / 24卷
关键词：
Preference-based measure of health; EQ-5D; SF-6D; Orphan disease, Pompe disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：837 / 844
页数：7
相关论文
共 50 条
  • [41] The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis
    M. J. Harrison
    L. M. Davies
    N. J. Bansback
    M. J. McCoy
    S. M. M. Verstappen
    K. Watson
    D. P. M. Symmons
    Quality of Life Research, 2009, 18 : 1195 - 1205
  • [42] Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis
    Roisin Adams
    Cathal Walsh
    Douglas Veale
    Barry Bresnihan
    Oliver FitzGerald
    Michael Barry
    PharmacoEconomics, 2010, 28 : 477 - 487
  • [43] Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis
    Adams, Roisin
    Walsh, Cathal
    Veale, Douglas
    Bresnihan, Barry
    FitzGerald, Oliver
    Barry, Michael
    PHARMACOECONOMICS, 2010, 28 (06) : 477 - 487
  • [44] The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure
    Nick Kontodimopoulos
    Michalis Argiriou
    Nikolaos Theakos
    Dimitris Niakas
    The European Journal of Health Economics, 2011, 12 : 383 - 391
  • [45] A CALIBRATION OF THE RELATIONSHIP BETWEEN THE HAQ, THE SF-6D AND THE EQ-5D IN INFLAMMATORY ARTHRITIS
    Adams, R.
    Walsh, C.
    Tilson, L.
    FitzGerald, O.
    Bresnihan, B.
    Veale, D.
    Barry, M.
    VALUE IN HEALTH, 2009, 12 (07) : A446 - A447
  • [46] The validity of estimating EQ-5D and SF-6D utility values from the HAP
    Harrison, Mark J.
    Lunt, Mark
    Bansback, Nick
    Verstapen, Suzanne
    Watson, Kath
    Symmons, Deborah
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S204 - S204
  • [47] PREDICTING EQ-5D, SF-6D AND 15D UTILITIES FROM EORTC QLQ-C30 DATA
    Kontodimopoulos, N.
    Paliouras, D.
    Pappa, E.
    Papadopoulos, A. A.
    Aletras, V. H.
    Niakas, D.
    VALUE IN HEALTH, 2008, 11 (06) : A341 - A341
  • [48] EQ-5D versus SF-6D in an older, chronically ill patient group
    Gerard K.
    Nicholson T.
    Mullee M.
    Mehta R.
    Roderick P.
    Applied Health Economics and Health Policy, 2004, 3 (2) : 91 - 102
  • [49] The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis
    Harrison, M. J.
    Davies, L. M.
    Bansback, N. J.
    McCoy, M. J.
    Verstappen, S. M. M.
    Watson, K.
    Symmons, D. P. M.
    QUALITY OF LIFE RESEARCH, 2009, 18 (09) : 1195 - 1205
  • [50] Evaluating a falls prevention intervention in older home care recipients: a comparison of SF-6D and EQ-5D
    Bjerk, Maria
    Brovold, Therese
    Davis, Jennifer C.
    Bergland, Astrid
    QUALITY OF LIFE RESEARCH, 2019, 28 (12) : 3187 - 3195
12345